An accomplished courtroom advocate and counselor to management teams and boards of directors, Robert helps life sciences companies of all sizes navigate business conflicts. His deep industry knowledge and experience, as well as his foundational industry education through a B.S.E. and M.S.E. in biomedical engineering, have enabled Robert to successfully guide numerous companies through all manner of patent, trade secret and commercial disputes.
Robert’s clients and engagements span the spectrum of large multinationals, including UCB, Loxo Oncology (an Eli Lilly company), Pfizer, Novo Nordisk, Google and Abiomed, through emerging and startup companies, such as AnaptysBio, Avalyn Pharma, Melinta Therapeutics, Passage Bio, and Sutro Biopharma.
Recognition Recognition Recognition
Recognition Recognition Recognition
2021 - 2022
Patents: Litigation (Full Coverage).
2014 - 2022
Rising Star, Intellectual Property Litigation.
2019
Rising Star List: Top Five Life Sciences Lawyers under 40.
2014
Impact Case of the Year Award for work representing Pfizer in case against Teva Pharmaceutical Industries Ltd.